• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Adenovirus vaccine cut infections by a factor of 100

Waverunner

Senior Member
Messages
1,079
Does anyone know if this vaccine is also available for non-military people? It works pretty good.

https://www.sciencenews.org/article/boot-camp-bug

The U.S. military has been fighting a battle with a common virus. Adenoviruses, which cause respiratory illnesses including some colds, plague boot camps. In the past, the viruses have infected 80 percent or more of new soldiers, spawning a potentially fatal flulike illness in some. A vaccine kept the virus in check for two decades but was discontinued in 1996, after a dispute between its maker — Wyeth Pharmaceuticals — and the U.S. Department of Defense. A new vaccine introduced by the DOD in 2011 has cut infections by a factor of 100, scientists report July 2 in Clinical Infectious Diseases.
 

Valentijn

Senior Member
Messages
15,786
Is it unduly cynical for me to wonder if there's any correlation between the DOD testing that vaccine during the development phases, and prevalence of GWS? :rolleyes:
 

Waverunner

Senior Member
Messages
1,079
Is it unduly cynical for me to wonder if there's any correlation between the DOD testing that vaccine during the development phases, and prevalence of GWS? :rolleyes:

Well, this should be easy to find out because it was discontinued from 1996 to 2011. Therefore I highly doubt, that it had influence on the prevalence of GWS.
 

Valentijn

Senior Member
Messages
15,786
Well, this should be easy to find out because it was discontinued from 1996 to 2011. Therefore I highly doubt, that it had influence on the prevalence of GWS.
The new one was "introduced" in 2011. Which means it was in development for a while prior to that.